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Abstract
Background: Influenza A virus displays strong reassortment characteristics, which enable it to achieve adaptation in human
infection. Surveying the reassortment and virulence of novel viruses is important in the prevention and control of an
influenza pandemic. Meanwhile, studying the mechanism of reassortment may accelerate the development of anti-influenza
strategies.
Methodology/Principal Findings: The hemagglutinin (HA) and neuraminidase (NA) matching patterns of two pandemic
H1N1 viruses (the 1918 and current 2009 strains) and a highly pathogenic avian influenza A virus (H5N1) were studied using
a pseudotyped particle (pp) system. Our data showed that four of the six chimeric HA/NA combinations could produce
infectious pps, and that some of the chimeric pps had greater infectivity than did their ancestors, raising the possibility of
reassortment among these viruses. The NA of H5N1 (A/Anhui/1/2005) could hardly reassort with the HAs of the two H1N1
viruses. Many biological characteristics of HA and NA, including infectivity, hemagglutinating ability, and NA activity, are
dependent on their matching pattern.
Conclusions/Significance: Our data suggest the existence of an interaction between HA and NA, and the HA NA matching
pattern is critical for valid viral reassortment.
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Introduction
Influenza A virus has caused several epidemics, including the
catastrophic H1N1 Spanish flu of 1918 (more than 50 million
deaths globally), the H2N2 Asian flu of 1957 (more than 1
million deaths globally), and the H3N2 Hong Kong flu of 1968
(,0.5 million deaths globally) [1–3]. In comparison, the current
outbreak of a novel H1N1 viral strain, which has become a
major global issue since April of 2009, has affected 177
countries, including more than 182,166 people, and caused
1,799 deaths to date [4]. Simultaneously, a highly pathogenic
avian influenza virus, H5N1, has been circulating in Eurasia for
more than a decade and has spread to more than 60 countries;
t h u sf a r ,i th a si n f e c t e d4 3 8h u m a n sa n dk i l l e d2 6 2[ 5 ] .A l t h o u g h
there are only rare reports of human- to-human H5N1
transmission to date, its high lethality has raised considerable
concern worldwide.
Influenza virus A is a genus in the Orthomyxoviridae family; its
genome contains eight negative single-stranded RNA segments
that encode eleven proteins (HA, NA, NP, M1, M2, NS1, NEP,
PA, PB1, PB1-F2, and PB2) and is subtyped based on 16
hemagglutinin (HA) and nine neuraminidase (NA) envelope
proteins [1]. Reassortment of the eight RNA segments may
produce additional novel viruses, at least theoretically [1–3].
Influenza A viruses are believed to enter host cells via HA binding
to sialic acid receptors on the cell surface; the binding affinity of
HA to sialic acid is believed to account in part for the host
specificity of several influenza A viral subtypes [1,6,7]. Human
viruses known to be capable of tropism preferentially bind to sialic
acid linked to galactose by a-2,6 linkages, while avian viruses of
this type tend to bind to a-2,3 linkages [7]. Many animals,
including swine, chickens, and humans, have both a-2,3 and a-2,6
linkages on their epithelial cells, which may serve as a ‘‘mixing
vessel’’ for the genesis of new viral types through co-infection
PLoS ONE | www.plosone.org 1 February 2010 | Volume 5 | Issue 2 | e9167[2,3,8]. In fact, genetic studies of the current H1N1 strain have
suggested that the virus contains a unique combination of gene
segments from both North American and Eurasian swine lineages,
of which PB2, PA, PB1, HA, NP, and NS are derived from a
North American swine lineage (triple reassortment), while NA and
M are derived from a Eurasian swine lineage [9,10]. In other
words, the current pandemic H1N1 virus carries a complex
genetic reassortment of previously prevalent viral strains [9,10].
Influenza A viral subtypes, including Spanish influenza H1N1,
the current pandemic H1N1 viruses, and influenza A viral subtype
HPAI H5N1, are catastrophic pathogens for humans [4,11–14].
Although the Spanish influenza H1N1 virus ultimately disap-
peared from surveillance, it’s possible that the strain remains on
Earth, and the reassortment of two or more catastrophic viruses
may present a challenge to human survival. Although we
understand the general mechanisms by which new influenza
viruses emerge, our basic knowledge of how these viruses reassort
and acquire human pandemic potential is limited, and our
molecular understanding of the virus and host factors involved in
successful transmission and spread is rudimentary.
Increasing industrialization and travel, and the huge popula-
tions of many influenza viral reservoir animals will likely accelerate
the emergence of novel viruses, especially those viruses that readily
reassort. Surveying new viral strains is one aspect of influenza virus
control and prevention. Thus, research on possible reassortment
among the HPAI H5N1, H1N1 2009, and H1N1 1918 viruses is
needed with regard to therapeutic target and preventive strategy
development. In this study, the HA and NA matching patterns and
biological properties of two pandemic H1N1 strains (Spanish
H1N1 1918 and the current strain) and a HPAI H5N1 strain were
studied using a newly established relative influenza virus
pseudotyped particle (pp) system. Our study provides important
biological information about these viruses.
Materials and Methods
Cell Culture
A549 cells and human embryonic kidney (HEK) 293T cells
(American Type Culture Collection, Manassas, VA) were grown in
Dulbecco’s modified essential medium (DMEM; Invitrogen,
Carlsbad, CA) supplemented with 10% fetal bovine serum.
Plasmid Construction
cDNA fragments encoding the full-length HA of A/South
Carolina/1/1918 (GenBank Acc. No. AF117241) and A/Califor-
nia/05/2009 (GenBank Acc. No. FJ966952) and the full-length
NA of A/Brevig_Mission/1/1918 (GenBank Acc. No. AF250356)
and A/Ohio/07/2009 (GenBank Acc. No. FJ969534) were
synthesized and inserted into the vector pVRC (Liuhetong Inc.,
Beijing, China) to produce the constructs 1918H1, 09H1, 1918N1,
and 09N1, respectively [15,16].
Similarly, cDNA fragments encoding the full-length HA and
NA from H5N1 (A/Anhui/1/2005, GenBank Acc. No.
DQ371928) were amplified and cloned into the vector pVRC;
they are referred to as AH H5 and AH N1, respectively.
Pp Production and Quantification
Pps were produced by transfecting 293T cells with four
plasmids: an HA expression plasmid, an NA expression plasmid,
a Gag-pol-encoding plasmid, and a reporter plasmid. At 72 h post-
transfection, pps were harvested from the supernatants of the
transfected cells by filtration through a 0.45-mm Durapore PVDF
membrane filter (Millipore Ireland, Cork, Ireland). For quantifi-
cation of pps, purified pps were treated with DNase/RNase to
eliminate the possible contamination of DNA/RNA, and CMV-
GFP RNA in pps was extracted by QIAamp UltraSens Virus Kit
(QIAGEN, CA). The amount of CMV-GFP RNA in each pps was
quantified by qRT-PCR using forward primer: CCCGTGAGT-
CAAACCGCTAT, reverse primer: GTGATGCGGTTTTGG-
CAGTA, and probe: FAM-CCACGCCCATTGATG-NFQ in an
ABI 7500 Fast (Applied Biosystem, Foster City, CA) with One
Step PrimeScript RT-PCR Kit (Takara, Japan), by which all pps
were normalized to the same cycle threshold (Ct) value to 12,13
prior to the following experiments including infection assay,
hemagglutination assay and NA activity detection and western blot
analysis of the HA and NA combinations.
Infection Assay
The pps infection assay was performed as reported previously
[15,16]. The naı ¨ve H1N1 virus HA0 must be matured by TPCK-
trypsin cleavage to form its functional subunits HA1 and HA2;
using optimal conditions for pp infection, normalized pps were
pre-treated with TPCK-trypsin at a final concentration of 40 mg/
mL at 37uC for 1 h before infection. A549 cells (5210610
3) were
seeded in a 96-well plate one day prior to infection. The
normalized pps were diluted 1:1 in 100 mL of DMEM. For the
infection process, the medium in the plate was replaced with the
diluted pps, allowed to stand for 4 h, and then replaced with
DMEM supplemented with 3% FBS. At 72 h post-infection, the
infected cells were rinsed twice with phosphate-buffered saline
(PBS). The number of GFP reporter-positive cells was determined
by FACS (BD FACSAria, BD Biosciences, Franklin Lakes, NJ).
Hemagglutination Assay
To determine the hemagglutinating activity of the pps, a
hemagglutination assay was performed. The normalized pp samples
were two-fold diluted serially in PBS at 50 mL per well. Next, 50-mL
aliquots of 1% turkey red blood cells were added to each well and
left to stand for 30 min; hemagglutination was then scored.
NA Activity Detection
To detect the level of NA activity in each HA and NA
combination, an NA activity assay was performed using the NA-
Star Influenza Neuraminidase Inhibitor Resistance Detection Kit
(Applied Biosystems, Foster City, CA). All reagents were prepared
according to the manufacturer’s instructions. For each sample,
normalized pps were diluted 1:1 in NA-Star Assay buffer (the same
concentration as in the infection assay) then incubated with 10 mL
of NA-Star substrate for 30 min at room temperature. The
samples were then analyzed using a luminometer (2103 Envision
Multilabel Reader, PerkinElmer, Waltham, MA).
Western Blot and Immunocellular Staining Analysis of the
HA and NA Combinations
To assess the existence of HA and NA in the pps, 2 mL
normalized pp combination were purified and concentrated to
20 mL using PEG-it
TM Virus Precipitation Solution (System
Bioscience, Mountain View, CA). To assess the HA and NA
expression in 293T producer cells, after pp harvest, the 293T cells
in 6-well plate were washed twice by PBS to remove residual
surpernatant and lysed in 500 mL of reporter lysis buffer (Promega,
WI) per well and centrifugated to remove cell debris. 20 mLo f
each sample (prepared pps and cell lysates) were loaded with 46
LDS sample buffer (Invitrogen, Carlsbad, CA) and heated to
100uC for 5 min and applied to electrophoresis using a 12%
NuPage gel (Invitrogen, Carlsbad, CA). After electrophoresis, the
gel was semi-dry transferred to a PVDF membrane (Pall Corp.,
HA and NA Matching Patterns
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membrane was blocked overnight in skim milk at 4uC. Following
incubation in primary antibody to HAs (antibodies to 09H1 and
1918H1 were provided by Sino Biological Inc, Beijing, China;
antibody to AH H5 was provided by Dr. Mifang Liang [17]) and
primary antibody to NAs (antibodies to 09N1, 1918N1 and AH
N1 were raised by our laboratory and purchased from Abcam,
Cambridge, MA) for 1.5 h at room temperature, the membrane
was washed three times in PBS. Next, the membrane was
incubated in corresponding biotinylated secondary antibody
(Vector Laboratories, CA) for 20 min at room temperature,
washed three times in PBS, and visualized by DAB SUBSTRATE
KIT (Vector Laboratories, CA).
To examine the HAs and NAs expression of all 9 combinations,
293T producer cells in 6-well plate were washed twice with PBS
and subsequently fixed them with 3.7% formaldehyde in PBS for 1
hour at room temperature. After washing the cells again with PBS,
we permeabilized the cells with 0.1% Tween 20 in PBS for 1 hour,
blocked the cells with PBS containing 2% normal serum for 1
hour, and incubated the cells with primary antibodies for 2 hours
at room temperature. We washed the cells 3 times with PBS and
then incubated the cells with FITC-conjugated secondary
antibodies (Dako, Carpinteria, CA) for1 hour at room tempera-
ture. After washing the cells with ice-cold PBS, we coated the cells
with fluorescent mounting medium (Dako), covered them with
glass coverslips, and observed the stained cells with a Nikon
Fluorescence Microscopy (Nikon, Japan).
Data Analysis
Significant differences were evaluated using a two-tailed Fisher’s
exact test (SPSS, release 12.1; SPSS Inc., Chicago, IL). Differences
were deemed to be statistically significant at p,0.05.
Results
Four of the Six Chimeric HA/NA Combinations Produced
Infectious Pps
HA and NA are envelope proteins located on the viral surface
that co-mediate the first stages of viral entry; thus, to achieve
successful infection for a given viral strain, the naı ¨ve HA and NA
should match each other well. Unlike the hepatitis C virus, where
the envelope proteins E1 and E2 form a heterodimer for viral
entry [18], HA and NA seem to be discrete on the viral surface, at
a ratio of about 4:1 [1], so it appears reasonable that the HA
should match the NAs in addition to its own spousal NA to
reassort [19,20]. We demonstrated previously that the chimeric
combination of 09 H1+1918 N1 and 1918 H1+09 N1 could form
infectious pps [15]. To further investigate whether the HA
matches the NA, rather than that belonging to the same subtype,
and to evaluate whether the above mentioned three catastrophic
influenza viruses can undergo reassortment, we generated pps
using the following combinations: 09N1+09H1, 1918N1+1918H1,
and AH N1+AH H5, as well as 09N1+AH H5, 09N1+1918H1,
1918N1+AH H5, 1918N1+09H1, AN N1+1918H1, and AH
N1+09H1. The combination of 09N1+09H1, 1918N1+1918H1,
and AH N1+AH H5 resulted in the formation of infectious pps,
with infectivities of 3.6060.85, 4.4561.20, and 6.0561.06%,
respectively (Fig. 1; dark blue bars). As expected, the combination
of 09N1+AH H5, 09N1+1918H1, 1918N1+AH H5, and
1918N1+09H1 also resulted in highly infectious pps, with
infectivities of 1.1560.07, 24.8565.16, 5.3560.35, and 5.156
0.64%, respectively (Fig. 1). Of the pps containing 09N1, the
combination of 09N1+1918H1 had greater infectivity than the
ancestor 09N1+09H1 (p,0.05). The pps containing 1918N1,
1918N1+AH H5, and 1918N1+09H1 also showed greater
infectivity than their ancestor, 1918N1+1918H1. 09N1+1918H1
also showed greater infectivity than another ancestor,
1918N1+1918H1 (p,0.05). Take together, these data suggest
that valid reassortment may occur not only between viruses
belonging to the same subtype (H1N1), but also between viruses
belonging to different subtypes (H1N1 and H5N1); furthermore,
some viruses, the products of reassortment, may have greater
infectivity than their ancestors.
Unexpectedly, of the combinations involving AH N1, only the
naı ¨ve combination AH N1+AH H5 produced infectious pps, while
AH N1+09H1 and AH N1+1918H1 displayed very low infectivity
(similar to that of HA alone), suggesting that the NA of H5N1 did
not match the HA belonging to H1N1 well (Fig. 1). In conclusion,
Figure 1. Infectivity assay of all combinations. Infectivity of normalized pps with various HA/NA combinations; infectivity is presented as the
Mean6 SD percentage of infected cells from 3 repeats. All pps were grouped by NA; 2009 H1N1, 1918 H1N1, and H5N1 (A/Anhui/1/2005) are
abbreviated as 09, 1918, and AH, respectively.
doi:10.1371/journal.pone.0009167.g001
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combinations could produce infectious pps, and that some of the
chimeric pps had greater infectivity than their ancestors, raising
concern about the possible reassortment of these viruses.
Meanwhile, the NA of H5N1 (A/Anhui/1/2005) was apparently
hard to reassort with the HAs of two other H1N1 viruses.
HA/NA Expression Analysis
To eliminate the possibility of differences in HA and NA
expression efficiency among all of the combinations and to further
assess the biological features of the HAs and NAs on all virions,
both pps and pp producer cells were subjected to Western blot
analysis. All primary antibodies for HAs could recognize the
linearizes HA0s well. Of the pps derived from AH H5, 1918H1
and 09H1 combined with 1918N1, 09N1, and AH N1, HAs
showed similar amount within each subgroup, all HAs displayed
similar molecular weight to purified wild influ viruses H5N1 and
H1N1. In the subgroup of the 1918H1 combined with 1918N1,
09N1, and AH N1, 1918H1 was relatively weak than other two
HAs, considering that 09N1+1918H1 hit the highest infectivity,
the difference in the ‘‘amount’’ of 1918H1 should be due to the
affinity of the primary antibody (Fig. 2A).
Of the NAs western blot analysis, we tired as many as ten strain
specific and non-specific primary antibodies, only in the cellular
lysate transfected by AH N1 could be recognized and visualized by
a Rabbit polyclonal to Avian Influenza A Neuraminidase (Abcam,
ab70759), this antibody could not make the AH N1 of the purified
wild H5N1 virus visible even the loading amount was five times
higher than that in HA detection (data not showed). This may be
explained by that many antibodies might only bind to conforma-
tional epitope in NA and the NA amount in the virons or
combinations was low.
To confirm the HAs and NAs expression in pp producer 293T
cells, after the pp harvested, 293T cells in 6-well plate were
subjected to immunocellular staining. For HAs expression, all
antibodies we used in western blot analysis could recognize the
HAs well, HAs in all combinations showed similar character in
subcellular location and expression efficiency (Fig. 2B bottom). For
NAs expression, many antibodies including Rabbit polyclonal to
Avian Influenza A Neuraminidase (Abcam, ab70759) could
Figure 2. HA/NA expression analysis. A. Western blot of HA. HA of each pp combination was blotted with purified 300ng wild viruses as positive
control (H5N1: A/Vietnam/1194/2005; H1N1: A/Carifornia/7/2009). B. Immunocellular staining of HA and NA on pp producer 293T cells. HA (bottom)
and NA (upper). Mock, normal 293T cell lysate.
doi:10.1371/journal.pone.0009167.g002
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subcellular location and expression efficiency (Fig. 2B upper).
In conclusion, although we failed to detect the NAs in pps, our
immunocellular staining showed that all HAs and NAs were
expressed equally in pp producer cells and our normalized pps
showed similar amount of HAs in all combinations, the difference
of infectivity among all combinations should be due to the HA NA
matching patterns.
Hemagglutination Among the Combinations
To further characterize the pps and to confirm the existence of
HA activity in the combinations, the normalized pp samples
generated from the nine combinations were subjected to a
hemagglutination assay. All pps were diluted two-fold serially in
this assay. The hemagglutinating abilities (log2) of 09N1+AH H5,
09N1+1918H1, and 09N1+09H1 (all containing NA from the
2009 H1N1 strain) were 5.362.1, 5.761.5, and 6.760.9,
respectively (Fig. 3); the naı ¨ve combination 09N1+09H1 displayed
the highest level of hemagglutination. Interestingly, the
09N1+1918H1 pps, which showed the greatest infectivity, did
not display the highest level of hemagglutination (Fig. 3 and Fig. 1).
The hemagglutination abilities (log2) of 1918N1+AH H5,
1918N1+1918H1, and 1918N1+09H1 (all containing NA from
the 1918 H1N1 strain) were 4.562.4, 560, and 6.361.7,
respectively (Fig. 3). The hemagglutinating abilities (log2)o fA H
N1+AH H5, AH N1+1918H1, and AH N1+09H1 (all containing
NA from the H5N1 strain) were 5.462.1, 161, and 4.962.1,
respectively (Fig. 3); For AH N1+1918H1 and AH N1+09H1
combinations which displayed very low infectivity, although AH
N1+1918H1 showed the lowest hemagglutinating ability, AH
N1+09H1 showed fair high hemagglutinating ability (Fig. 3).
Taken together, our data suggested that hemagglutinating ability
seemed to have no relationship with infectivity.
NA Activity in the Pps
To determine the level of NA activity in the pps, normalized pp
samples generated from the nine combinations were subjected to
NA activity assays. NA activity in the pps containing the NA
from the 2009 H1N1, 1918 H1N1, and H5N1 strains was
264513361754985, 45027661835, and 13684618463 chemilu-
minescent units, respectively, indicating a tendency from high to
low. NA activity in the pps containing 2009NA was significantly
higher than in those containing 1918NA and H5N1 NA
(p=0.0022 and 0.0019, respectively; Fig. 4). This tendency was
consistent with the degree of infectivity (Fig. 1). Focusing on the
groups categorized by the three NAs, in the pp group containing
2009NA, the NA activities of 09N1+09H1, 09N1+1918H1, and
09N1+AH H5 were 451145361334912, 24770806743487, and
9468676625996 chemiluminescent units, respectively. Thus, the
level of NA activity in 09N1+09H1 was significantly higher than
that in 09N1+1918H1 or 09N1+AH H5 (p=0.049 and 0.013,
respectively; Fig. 4A). In the pp group containing 1918NA, the
level of NA activity in 1918N1+1918H1, 1918N1+09H1, and
1918N1+AH H5 was 840062892, 113920667540, and
1276065557 chemiluminescent units, respectively. Thus, the
NA activity of 1918N1+09H1 was higher than that of its ancestor
1918N1+1918H1 (Fig. 4B). In the pp group containing AH NA,
the NA activities of AH N1+AH H5, AH N1+09H1, and AH
N1+1918 H1 were 12827611499, 26333627953, and 18936583
chemiluminescent units, respectively. Thus, the NA activity of AH
N1+09H1 was higher than that of its ancestor AH N1+AH H5
(Fig. 4C). Taken together, NA activity varied immensely between
the strains. Furthermore, the level of NA activity showed a spouse-
dependent tendency; HA appeared to be able to raise the activity
of all of the NAs, especially the HA from the 2009 H1N1 strain.
Primary Sequence Analysis of Three HA/NA
Combinations
To standardize the research, amino acid sequences, we aligned
the primary sequences of the HAs from A/South Carolina/1/
1918 (GenBank Acc. No. AF117241), A/California/05/2009
(GenBank Acc. No. FJ966952), and A/Anhui/1/2005 (GenBank
Acc. No. DQ371928) and of the NAs from A/Brevig_Mission/1/
1918 (GenBank Acc. No. AF250356), A/Anhui/1/2005 (Gen-
Bank Acc. No. DQ371928), and A/Ohio/07/2009 (GenBank
Acc. No. FJ969534) using the HA and NA from the 1918 strain as
standards. Residues identical to those in the 1918 strain were
replaced by ‘‘.’’; the aas in red represent the cleavage site of the
HA precursor, linking the functional HA1 and HA2 domains; bold
indicates the signal peptide; blue indicates the sialic acid receptor
Figure 3. Hemagglination assay of various pps. All pps were two-fold diluted serially in 96-well plate. The hemagglutinating ability was
expression as the mean HA titer (log2 HA units/50 ml) of each pp, n=3.
doi:10.1371/journal.pone.0009167.g003
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predicted from the HA1 sequence; and the green box indicates the
residues corresponding to the active site of NA (Fig. 5).
Of the 569 aas in HA, 79 (13.88%) and 200 (35.15%) aa
differences were detected in the HAs of the 2009 and H5N1 strains
compared to those of the 1918 strain, respectively (Fig. 5).
Figure 4. NA activity in the various pps, NA activity is presented as the Mean6 SD from 3 repeats. A. NA activity of 09N1 combined with
09H1, 1918H1, and AH H1. B. NA activity of 1918N1 combined with 1918H1, 09H1, and AH H1. C. NA activity of AH N1 combined with AH H1, 09H1,
and 1918H1.
doi:10.1371/journal.pone.0009167.g004
Figure5. Primary sequence alignment of the HAs and NAs. TheH1N1 1918 strain was used as a standard. Those residues that areidentical in the
1918 strain are shown by ‘‘.’’ The signal peptide is indicated in bold. The aas marked in red represent the cleavage site of the HA precursor, linking the
functional HA1 and HA2 domains, while those marked in blue indicate the binding sites for the sialic acid receptor. The gray boxes indicate potential
glycosylation sites, as predicted from the sequence, while the green box indicates conserved active site residues from the influenza virus NA.
doi:10.1371/journal.pone.0009167.g005
HA and NA Matching Patterns
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strains, the HA of H5N1 displayed similar glycosylation and
receptor binding sites to the H1N1 strains. Together with the fact
that the HA from H5N1 could match not only its naı ¨ve NA but
also the NAs from the 2009 and 1918 strains, the HA of H5N1
would be expected to share biological features, including an
affinity for NA, with that of the two H1N1 strains.
Of the 469 aas in NA, 59 (12.85%) of those in 09NA and 52
(11.09%) of those in the NA from H5N1 were different from those
in the 1918 strain (Fig. 5). Although the NA of H5N1 showed less
variation than the H1N1 strains, as many as 20 aas, at positions
49–68, were absent (Fig. 5).
Discussion
The high mutation rate in minus-strand RNA viruses, the ability
of gene segments to reassort, the transmission route, and the huge
pool of influenza viruses in birds and mammals ensure their
continuously changing behavior [21]. Thus, the survey of
reassortment and virulence is a key aspect in the prevention and
control of influenza pandemics. The surface proteins of influenza
viruses, HA and NA, play important roles in virulence, host
specificity, and the human immune response [1]. In this study, we
evaluated the HA and NA matching patterns of two pandemic
H1N1 viruses (1918 and the current 2009 strain) and a highly
pathogenic avian influenza A virus (H5N1) using a retroviral pp
system. Our data show that four of the six chimeric HA/NA
combinations produced infectious pps and that some of the
chimeric pps had greater infectivity than did their ancestors,
raising the possibility of reassortment in these viruses.
Influenza A viruses belong to the family Orthomyxoviridae. On the
basis of the antigenicity of their HA and NA molecules, they are
classified into 16 HA subtypes (H1-H16) and nine NA subtypes
(N1-N9) [1]. Thus, theoretically there should be 144 subtypes.
However, historically, only a few subtypes of influenza virus have
ever produced epidemics or pandemics in humans, including
H1N1, H2N2, and H3N2 [2,3]. These pandemic viruses showed
clear features of genetic reassorment; eight gene fragments were
originally derived from avian viruses [22], while HA, PB1, and/or
NA alone were derived from avian viruses [23,24]. Thus, HA and
NA play important roles in the emergence and global transmission
of novel viruses in humans. Recently, HPAI H5N1 [25,26] was
directly transmitted to humans, like the avian flu viruses H7N7
[27], H9N2 [28], and H5N2 [29]; however, the human-to-human
transmission of these viruses is limited [2,3]. The above evidence
suggests certain limiting factors among the subtypes of viruses
regarding valid reassorments and pandemics. Many factors can
influence influenza virus transmission and spread [30]. Our study
demonstrates that N1 from H5N1 did not match well with the two
HAs from H1N1, indicating that the HA/NA matching pattern is
an important factor in determining the strain’s virological
properties. The continuing outbreaks in poultry and birds caused
by H5N1 with the 20-aa deletion in the NA stalk region, which
emerged in 1999 [31], suggest that this NA prefers avian hosts.
Our data show that the naı ¨ve combination of AH N1+AH H5
displayed strong infectivity in A549 cells, seemingly removing the
possibility that the weak infectivity of the AH N1+1918H1 and
AH N1+09H1 combinations was not caused by species restric-
tions. The deletion of aas 49–68 in AH N1 may be important in
HAs NAs interaction, but a study showed that deletions of up to 28
amino acids and insertions of up to 41 amino acids in the stalk
region did not abolish formation of infectious progeny virus [32].
So AH N1 might has strong species restriction and this restriction
may limit the H5N1 transmission among human.
For the NAs detection in pps, although we failed to demonstrate
the incorporation of HAs into nine pps, our NA activity assay
showed that all NAs did display enzyme activity, the infectivity
assay showed that NAs did participate in the infection, and the
immunocellular staining showed that all NAs expressed at the
same level. In fact, study showed that the NA amount is not more
than 1/40 of the HA amount in wild influ virus [33], not like the
statement NA/HA is 1/4 [1], so the failure of NAs detection may
also be partially due to the low amount of NAs in pps and we
believe that the variation in infectivity should be not due to the
difference of NAs incorporation. There are many possible
hypotheses to explain in the increase and decrease NA activity
including the incorporated amount of NA in each kind of pps and
the interaction between a given HA and a certain NA, we will try
to explain this issue in our following experiments.
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